Skip to content
HowShorted

Medicines Company (The) short interest in 2019

In 2019, Medicines Company (The)'s disclosed short interest ran from 27.38% of shares outstanding on 15 Jan 2019 to 35.08% on 31 Dec 2019, a change of +7.70 percentage points. The year's high was 35.08% on 31 Dec 2019 and its low 25.89% on 15 Apr 2019, averaging 28.75% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.89 days on 15 May 2019. Full history: Medicines Company (The).

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019

Aggregate net short position time series for Medicines Company (The) in 2019

2019 in figures

Start of year
27.38% (15 Jan 2019)
End of year
35.08% (31 Dec 2019)
Change
+7.70 pp
High
35.08% (31 Dec 2019)
Low
25.89% (15 Apr 2019)
Average
28.75%
Highest days to cover
24.89 (15 May 2019)
SEC filings marked
8

Every report in 2019

Medicines Company (The) short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201927.38%14.42
31 Jan 201927.67%15.69
15 Feb 201928.55%22.44
28 Feb 201927.57%23.4610-K filed, results (8-K)
15 Mar 201927.40%15.56
29 Mar 201926.80%21.72
15 Apr 201925.89%21.46
30 Apr 201926.20%16.91results (8-K), 10-Q filed
15 May 201926.48%24.89
31 May 201926.59%12.33
14 Jun 201927.84%13.87
28 Jun 201931.14%9.27
15 Jul 201928.96%14.05
31 Jul 201926.47%17.7010-Q filed, results (8-K)
15 Aug 201926.84%20.11
30 Aug 201928.46%7.32
13 Sep 201929.04%6.94
30 Sep 201930.69%9.34
15 Oct 201930.93%17.92
31 Oct 201931.83%14.3610-Q filed, results (8-K)
15 Nov 201931.77%17.97
29 Nov 201928.92%1.82
13 Dec 201931.58%6.94
31 Dec 201935.08%12.63

See also: Medicines Company (The)'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.